Literature DB >> 30672576

A high linoleic acid diet exacerbates metabolic responses and gut microbiota dysbiosis in obese rats with diabetes mellitus.

Hsiu-Chuan Lee1, Shao-Chuan Yu, Yun-Chun Lo, I-Hsuan Lin, Te-Hsuan Tung, Shih-Yi Huang.   

Abstract

Dietary polyunsaturated fatty acid (PUFA) levels may affect inflammatory responses and lipid metabolism. Gut microbiota diversity is strongly associated with chronic inflammatory disease, diabetes mellitus (DM), and obesity through abnormal energy homeostasis. In this study, the association between metabolic responses and gut microbiota diversity at different dietary n-6/n-3 PUFA ratios was evaluated in DM rats. Obesity and DM were induced in rats by using a high-fat diet and streptozotocin (STZ), respectively. The obese DM rats were assigned to three groups and administered regular (R), high (H), and low (L) n-6/n-3 ratio diets (n-6/n-3 = 6.39, 3.02, and 9.29, respectively) for 6 weeks. Some metabolic parameters and gut microbiota of the rats were analysed. The results revealed that a high linoleic acid diet increased the plasma and kidney interleukin 6 levels, whereas a low n-6/n-3 ratio diet ameliorated blood glucose homeostasis, reduced plasma tumour necrosis factor α levels, and inhibited systematic inflammation. DM rats exhibited low gut microbiota diversity; however, compared with the R group, the L and H groups did not exhibit alterations in the α-diversity (Observed, Chao 1, Shannon and Simpson). The percentage of Firmicutes was lower in the DM groups than in the non-DM group; however, the L group showed a nonsignificantly higher Firmicutes/Bacteroidetes ratio than did the other groups. Thus, a low n-6/n-3 ratio diet can improve blood glucose homeostasis, reduce systematic inflammation, ameliorate glomerular basal membrane thickening, reduce the expression of receptors of advanced glycation end products in renal vessel walls, and prevent diabetic nephropathies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30672576     DOI: 10.1039/c8fo02423e

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  9 in total

1.  Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics.

Authors:  Yong-Jun Cao; Han-Zhou Li; Jie Zhao; Yu-Meng Sun; Xiao-Wen Jin; Shu-Quan Lv; Jun-Yu Luo; Xi-Xing Fang; Wei-Bo Wen; Jia-Bao Liao
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-08       Impact factor: 2.650

Review 2.  Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.

Authors:  Denisa Margină; Anca Ungurianu; Carmen Purdel; George Mihai Nițulescu; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Tatyana I Burykina; Fotis Tekos; Aleksandra Buha; Dragana Nikitovic; Demetrios Kouretas; Aristidis Michael Tsatsakis
Journal:  Food Chem Toxicol       Date:  2020-07-05       Impact factor: 6.023

Review 3.  Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis.

Authors:  David Johane Machate; Priscila Silva Figueiredo; Gabriela Marcelino; Rita de Cássia Avellaneda Guimarães; Priscila Aiko Hiane; Danielle Bogo; Verônica Assalin Zorgetto Pinheiro; Lincoln Carlos Silva de Oliveira; Arnildo Pott
Journal:  Int J Mol Sci       Date:  2020-06-08       Impact factor: 5.923

4.  An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens.

Authors:  Jing Shao; Yi Liu; Huan Wang; Yun Luo; Lei Chen
Journal:  Oxid Med Cell Longev       Date:  2020-05-27       Impact factor: 6.543

5.  Egg oil from Portunus trituberculatus alleviated obesity and regulated gut microbiota in mice.

Authors:  Shiwei Hu; Huicheng Yang; Xiang Gao; Shijie Li; Wei Jiang; Yu Liu
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

6.  Erythrocyte n-6 Polyunsaturated Fatty Acids, Gut Microbiota, and Incident Type 2 Diabetes: A Prospective Cohort Study.

Authors:  Zelei Miao; Jie-Sheng Lin; Yingying Mao; Geng-Dong Chen; Fang-Fang Zeng; Hong-Li Dong; Zengliang Jiang; Jiali Wang; Congmei Xiao; Menglei Shuai; Wanglong Gou; Yuanqing Fu; Fumiaki Imamura; Yu-Ming Chen; Ju-Sheng Zheng
Journal:  Diabetes Care       Date:  2020-07-28       Impact factor: 19.112

7.  Gut Microbiota Interplay With COVID-19 Reveals Links to Host Lipid Metabolism Among Middle Eastern Populations.

Authors:  Mohammad Tahseen Al Bataineh; Andreas Henschel; Mira Mousa; Marianne Daou; Fathimathuz Waasia; Hussein Kannout; Mariam Khalili; Mohd Azzam Kayasseh; Abdulmajeed Alkhajeh; Maimunah Uddin; Nawal Alkaabi; Guan K Tay; Samuel F Feng; Ahmed F Yousef; Habiba S Alsafar
Journal:  Front Microbiol       Date:  2021-11-05       Impact factor: 6.064

8.  Integrated analysis of proteomics and metabolomics in girls with central precocious puberty.

Authors:  Mei Li; Dan Lan; Yanfei Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

9.  San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism.

Authors:  Xiuhai Su; Wenxia Yu; Airu Liu; Congxiang Wang; Xiuzhen Li; Juanjuan Gao; Xiaofei Liu; Wenhui Jiang; Yue Yang; Shuquan Lv
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.